You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The public-private partnership has published a paper on a list of indels larger than 50 bp that is already being used to develop new methods.
Verily is adapting its Project Baseline to study the immune system response to SARS-CoV-2, CNBC reports.
Cerevance, a drug discovery firm employing the transcriptome sequencing method, raised $45 million in Series B financing earlier this month.
The company is also participating in a study, being conducted at Hannover Medical School, investigating the genetics of susceptibility to COVID-19.
The White House earlier this week announced a supercomputer consortium to uncover or develop drugs to address the COVID-19 pandemic, according to NPR.
A trio of Senators were unimpressed with the lack of detail Google provided them regarding Project Nightingale, and they want answers.
Google's Project Nightingale has collected health information on millions of Americans, according to the Wall Street Journal.
A lawsuit alleges the University of Chicago shared medical record data with Google that included information that should not have been, according to the New York Times.
The informatics firms signed agreements to offer certain of their genomic data technologies on Google's cloud-based computing services platform.
Microba currently offers a direct-to-consumer gut microbiome profile product and plans to release additional products for clinical and research use cases.
The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.
Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.
A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.
In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.